{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:37:26Z","timestamp":1767145046003,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.ejps.2013.08.031","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:00:00Z","timestamp":1390435200000}}],"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejps.2013.08.031","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:45:11Z","timestamp":1377881111000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["RETRACTED: Results from a 12 months, randomized, clinical trial comparing an olmesartan\/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation"],"prefix":"10.1016","volume":"51","author":[{"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arrigo F.G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Querci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fogari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejps.2013.08.031_b0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1291\/hypres.29.865","article-title":"Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme","volume":"29","author":"Agata","year":"2006","journal-title":"Hypertens. Res."},{"issue":"8","key":"10.1016\/j.ejps.2013.08.031_b0010","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejps.2013.08.031_b0015","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"Bindom","year":"2010","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ejps.2013.08.031_b0020","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1210\/en.2007-0175","article-title":"Chemerin is a novel adipokine associated with obesity and metabolic syndrome","volume":"148","author":"Bozaoglu","year":"2007","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.ejps.2013.08.031_b0025","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ejps.2013.08.031_b0030","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clinthera.2008.04.002","article-title":"The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study","volume":"30","author":"Chrysant","year":"2008","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2013.08.031_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ki.1989.1","article-title":"Regulation of the Na+K+-pump in skeletal muscle","volume":"35","author":"Clausen","year":"1989","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejps.2013.08.031_b0040","first-page":"214","article-title":"Glucose clamp technique, a method for quantifying insulin secretion and resistance","volume":"237","author":"De Fronzo","year":"1979","journal-title":"Am. J. Physiol."},{"issue":"6","key":"10.1016\/j.ejps.2013.08.031_b0045","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2337\/db06-1506","article-title":"Omentin plasma levels and gene expression are decreased in obesity","volume":"56","author":"De Souza Batista","year":"2007","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ejps.2013.08.031_b0050","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1586\/erc.10.51","article-title":"Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients","volume":"8","author":"Derosa","year":"2010","journal-title":"Expert Rev. Cardiovasc. Ther."},{"issue":"5","key":"10.1016\/j.ejps.2013.08.031_b0055","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1517\/14740338.2011.585966","article-title":"Drug safety evaluation of amlodipine","volume":"10","author":"Derosa","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.ejps.2013.08.031_b0060","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"issue":"suppl. 3","key":"10.1016\/j.ejps.2013.08.031_b0065","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0272-6386(93)70122-F","article-title":"Cytosolic calcium and insulin resistance","volume":"21","author":"Draznin","year":"1993","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.ejps.2013.08.031_b0070","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-5491.1999.00166.x","article-title":"A desktop guide to type 2 diabetes mellitus","volume":"16","author":"European Diabetes Policy Group","year":"1999","journal-title":"Diabet. Med."},{"issue":"6","key":"10.1016\/j.ejps.2013.08.031_b0075","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM198708063170605","article-title":"Insulin resistance in essential hypertension","volume":"317","author":"Ferrannini","year":"1987","journal-title":"New Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ejps.2013.08.031_b0080","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2169\/internalmedicine.47.1427","article-title":"Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients","volume":"47","author":"Fogari","year":"2008","journal-title":"Int. Med."},{"issue":"3","key":"10.1016\/j.ejps.2013.08.031_b0085","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/FJC.0b013e318160b42a","article-title":"Comparative evaluation of effect of valsartan\/amlodipine and atenolol\/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus","volume":"51","author":"Fogari","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2013.08.031_b0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/10641960903265212","article-title":"Time to achieve blood pressure goal with a combination versus a conventional monotherapy approach in hypertensive patients with metabolic syndrome","volume":"32","author":"Fogari","year":"2010","journal-title":"Clin. Exp. Hypertens."},{"issue":"1","key":"10.1016\/j.ejps.2013.08.031_b0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12325-010-0002-0","article-title":"Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients","volume":"27","author":"Fogari","year":"2010","journal-title":"Adv. Ther."},{"issue":"16","key":"10.1016\/j.ejps.2013.08.031_b0100","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1517\/14656566.2011.623698","article-title":"Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients","volume":"12","author":"Fogari","year":"2011","journal-title":"Expert Opin. Pharmacother."},{"issue":"8","key":"10.1016\/j.ejps.2013.08.031_b0105","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1517\/14656566.2012.683175","article-title":"Effects of valsartan or ramipril addition to amlodipine\/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy","volume":"13","author":"Fogari","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejps.2013.08.031_b0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MEG.0b013e32834ba188","article-title":"Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis","volume":"24","author":"Fogari","year":"2012","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2013.08.031_b0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low density lipoprotein in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin. Chem."},{"issue":"38","key":"10.1016\/j.ejps.2013.08.031_b0120","doi-asserted-by":"crossref","first-page":"28175","DOI":"10.1074\/jbc.M700793200","article-title":"Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism","volume":"82","author":"Goralski","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2013.08.031_b0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.290.2.199","article-title":"Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988\u20132000","volume":"290","author":"Hajjar","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejps.2013.08.031_b0130","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejps.2013.08.031_b0135","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF01225569","article-title":"Determination of total serum insulin (IRI) in insulin-treated diabetic patients","volume":"8","author":"Heding","year":"1972","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejps.2013.08.031_b0140","first-page":"121","article-title":"Enzymatische bestimmung des gesamtcholesterins mit dem greiner selective analyzer (GSA II)","volume":"15","author":"Klose","year":"1978","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.ejps.2013.08.031_b0145","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1517\/14656566.6.6.863","article-title":"Therapeutic perspectives of adipocytokines","volume":"6","author":"Kralisch","year":"2005","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejps.2013.08.031_b0150","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1161\/01.ATV.0000238352.25222.5e","article-title":"Summary of American heart association diet and lifestyle recommendations revision 2006","volume":"26","author":"Lichtenstein","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.ejps.2013.08.031_b0155","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/CIRCULATIONAHA.108.191261","article-title":"Heart disease and stroke statistics \u2013 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejps.2013.08.031_b0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cmet.2007.08.010","article-title":"The rapidly expanding family of adipokines","volume":"6","author":"MacDougald","year":"2007","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.ejps.2013.08.031_b0165","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejps.2013.08.031_b0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejps.2013.08.031_b0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1573402054022285","article-title":"Angiotensin II receptor blocker as an inverse agonist: a current perspective","volume":"1","author":"Miura","year":"2005","journal-title":"Curr. Hypertens. Rev."},{"issue":"2","key":"10.1016\/j.ejps.2013.08.031_b0180","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1751-7176.2010.00392.x","article-title":"Barriers to blood pressure control: a STITCH substudy","volume":"13","author":"Nelson","year":"2011","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"issue":"3","key":"10.1016\/j.ejps.2013.08.031_b0185","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1161\/01.HYP.0000200702.76436.4b","article-title":"Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals","volume":"47","author":"Okonofua","year":"2006","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.ejps.2013.08.031_b0190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.HYP.0000252676.46043.18","article-title":"Prevalence, awareness, treatment, and control of hypertension among United States adults 1999\u20132004","volume":"49","author":"Ong","year":"2007","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ejps.2013.08.031_b0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3810\/pgm.2009.03.1974","article-title":"Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy","volume":"121","author":"Oparil","year":"2009","journal-title":"Postgrad. Med."},{"issue":"12","key":"10.1016\/j.ejps.2013.08.031_b0200","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","article-title":"Clinical efficacy of an automated high-sensitivity C-reactive protein assay","volume":"45","author":"Rifai","year":"1999","journal-title":"Clin. Chem."},{"issue":"14","key":"10.1016\/j.ejps.2013.08.031_b0205","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20133","key":"10.1016\/j.ejps.2013.08.031_b0210","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbaexp.2005.11.005","article-title":"Genomic structure of human omentin, a new adipocytokine expressed in omental adipose tissue","volume":"1732","author":"Sch\u00e4ffler","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejps.2013.08.031_b0215","doi-asserted-by":"crossref","first-page":"C87","DOI":"10.1016\/0303-7207(90)90110-T","article-title":"At the cutting edge: insulin resistance and hypertension","volume":"74","author":"Sowers","year":"1990","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ejps.2013.08.031_b0220","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1291\/hypres.31.2011","volume":"31","author":"Teramoto","year":"2008","journal-title":"Hypertens. Res."},{"issue":"3","key":"10.1016\/j.ejps.2013.08.031_b0225","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","article-title":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy","volume":"41","author":"Tikellis","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejps.2013.08.031_b0230","series-title":"Methods of Enzymatic Analysis","first-page":"18","article-title":"Triglycerides determination after enzymatic hydrolysis","author":"Wahlefeld","year":"1974"},{"key":"10.1016\/j.ejps.2013.08.031_b0235","series-title":"Statistical Principles in Experimental Design","author":"Winer","year":"1971"},{"issue":"7","key":"10.1016\/j.ejps.2013.08.031_b0240","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20030382","article-title":"Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids","volume":"198","author":"Wittamer","year":"2003","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.ejps.2013.08.031_b0245","doi-asserted-by":"crossref","first-page":"E1253","DOI":"10.1152\/ajpendo.00572.2004","article-title":"Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action","volume":"290","author":"Yang","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejps.2013.08.031_b0250","first-page":"1","article-title":"Recent trends in the prevalence of high blood pressure and its treatment and control, 1999\u20132008","volume":"48","author":"Yoon","year":"2010","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ejps.2013.08.031_b0255","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.CIR.103.9.1194","article-title":"C-reactive protein-mediated lipoprotein uptake by macrophages","volume":"103","author":"Zwacka","year":"2001","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/j.ejps.2018.08.039","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2014,1,22]],"date-time":"2014-01-22T00:00:00Z","timestamp":1390348800000},"record-id":"16562"},{"DOI":"10.1016\/j.ejps.2018.08.039","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T00:00:00Z","timestamp":1539561600000}},{"DOI":"10.1016\/j.ejps.2013.08.031","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T00:00:00Z","timestamp":1390435200000}}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871300345X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092809871300345X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T19:03:01Z","timestamp":1596394981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092809871300345X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":51,"alternative-id":["S092809871300345X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2013.08.031","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Results from a 12months, randomized, clinical trial comparing an olmesartan\/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2013.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}